Stay updated on ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:22:02.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include new drug information, specifically the addition of Telisotuzumab vedotin and Erlotinib, while significant details about the ABBV-399 study, including its design and inclusion criteria, have been removed.
    Difference
    32%
    Check dated 2025-04-16T20:30:49.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 26, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T14:11:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 26, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-02T00:13:18.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The webpage has updated its date references to 2025 and modified the location formatting for Seoul, Korea. Additionally, there is a duplicate entry for the Henry Ford Health System.
    Difference
    2%
    Check dated 2025-03-04T03:54:22.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:01:58.000Z thumbnail image

Stay in the know with updates to ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.